The activity and protein expression of endothelial nitric oxide syntha
se (eNOS) and inducible NOS (iNOS) were investigated during the develo
pment of hypertension in spontaneously hypertensive rats (SHR). SHR an
d Wistar-Kyoto rats (WKY) were studied at three different ages: 4, 14
to 17, and 63 weeks of age. After treatment with saline or lipopolysac
charide (LPS, 10 mg/kg IV) for 3 hours, the aortas were removed for me
asurement of NOS activity and protein expression assay by [H-3]-L-citr
ulline formation method and Western blot analysis, respectively. Plasm
a levels of nitrite/nitrate (NO2-/NO3-) and tumor necrosis factor-alph
a (TNF-alpha) were also determined. At 14 to 17 weeks and 63 weeks, th
e basal activity and protein expression of eNOS in the aortas were sig
nificantly lower in SHR than in WKY. In addition, the aged WKY exhibit
ed lower eNOS activity than that of adult WKY, but this change was not
seen in SHR. By comparison, the basal activity and protein expression
of iNOS were only observed in SHR of the 14-to-17-week group and in t
he 63-week group; SHR still exhibited higher activities, and these dif
ferences were further exaggerated by treatment with LPS. The basal and
LPS-induced NO2-/NO3- and TNF-alpha levels in the plasma were also hi
gher in the SHR except the 4-week group. After treatment with quinapri
l, the basal and LPS-induced expressions of iNOS in SHR were significa
ntly attenuated. Our results demonstrated that alterations of activity
and protein expression of eNOS and iNOS occurred in SHR. In addition,
aging may reduce the activity of eNOS in WKY but not in SHR. The decl
ine of eNOS activity and/or expression may contribute to the developme
nt of hypertension, whereas the increase of iNOS expression may be a c
onsequence of the pathological state of vessels associated with hypert
ension in SHR. However, the augmented expression of iNOS in SHR was at
tenuated by antihypertensive therapy, suggesting that the abnormal exp
ression of iNOS is associated with hypertension.